• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cannabis Stock Gainers And Losers From July 15, 2024

    7/15/24 4:30:05 PM ET
    $CARA
    $CGC
    $EAST
    $GENE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $CARA alert in real time by email

    GAINERS:

    • Australis Capital (OTC:AUSAF) shares closed up 9900.00% at $0.01
    • Global Hemp Group (OTC:GBHPF) shares closed up 70.36% at $0.05
    • Maple Leaf Green World (OTC:MGWFF) shares closed up 68.48% at $0.05
    • CordovaCann (OTC:LVRLF) shares closed up 42.50% at $0.06
    • Target Group (OTC:CBDY) shares closed up 25.00% at $0.00
    • Blueberries Medical (OTC:BBRRF) shares closed up 19.09% at $0.01
    • CLS Holdings USA (OTC:CLSH) shares closed up 17.00% at $0.04
    • Zelira Therapeutics (OTC:ZLDAF) shares closed up 15.32% at $0.55
    • Leafbuyer Techs (OTC:LBUY) shares closed up 14.67% at $0.02
    • Canopy Gwth (NASDAQ:CGC) shares closed up 10.92% at $7.14
    • SOL Glb Inv (OTC:SOLCF) shares closed up 10.66% at $0.05
    • Cansortium (OTC:CNTMF) shares closed up 9.71% at $0.11
    • Rocky Mountain High (OTC:RMHB) shares closed up 7.69% at $0.01
    • Genetic Technologies (NASDAQ:GENE) shares closed up 6.89% at $0.92
    • Affinor Growers (OTC:RSSFF) shares closed up 6.05% at $0.07
    • GrowGeneration (NASDAQ:GRWG) shares closed up 5.15% at $2.47
    • Urban-gro (NASDAQ:UGRO) shares closed up 3.33% at $1.47

    LOSERS:

    • Elixinol Wellness (OTC:ELLXF) shares closed down 20.00% at $0.00
    • Kaya Holdings (OTC:KAYS) shares closed down 18.96% at $0.04
    • Eastside Distilling (NASDAQ:EAST) shares closed down 15.97% at $1.01
    • Body and Mind (OTC:BMMJ) shares closed down 15.83% at $0.03
    • 4Front Ventures (OTC:FFNTF) shares closed down 10.50% at $0.08
    • CNBX Pharmaceuticals (OTC:CNBX) shares closed down 9.86% at $0.01
    • Global Compliance (OTC:FUAPF) shares closed down 7.85% at $0.01
    • CV Sciences (OTC:CVSI) shares closed down 5.21% at $0.05
    • MariMed (OTC:MRMD) shares closed down 4.12% at $0.16
    • Cara Therapeutics (NASDAQ:CARA) shares closed down 3.17% at $0.34
    • Nextleaf Solutions (OTC:OILFF) shares closed down 3.16% at $0.06

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $CARA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CARA
    $CGC
    $EAST
    $GENE

    CompanyDatePrice TargetRatingAnalyst
    Canopy Growth Corporation
    $CGC
    11/10/2025Sell → Hold
    The Benchmark Company
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$6.00 → $1.00Buy → Hold
    Stifel
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$10.00 → $1.00Buy → Hold
    Canaccord Genuity
    Cara Therapeutics Inc.
    $CARA
    6/13/2024Buy → Hold
    Needham
    Cara Therapeutics Inc.
    $CARA
    6/13/2024Buy → Neutral
    H.C. Wainwright
    GrowGeneration Corp.
    $GRWG
    3/20/2024Outperform → Perform
    Oppenheimer
    GrowGeneration Corp.
    $GRWG
    5/10/2023$4.25 → $4.75Hold → Buy
    Craig Hallum
    Canopy Growth Corporation
    $CGC
    4/4/2023Underperform → Mkt Perform
    Bernstein
    More analyst ratings

    $CARA
    $CGC
    $EAST
    $GENE
    SEC Filings

    View All

    urban-gro Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - urban-gro, Inc. (0001706524) (Filer)

    3/9/26 9:00:20 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    urban-gro Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Other Events, Financial Statements and Exhibits

    8-K - urban-gro, Inc. (0001706524) (Filer)

    3/5/26 5:25:42 PM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    urban-gro Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - urban-gro, Inc. (0001706524) (Filer)

    2/25/26 5:00:52 PM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    $CARA
    $CGC
    $EAST
    $GENE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GrowGeneration Announces Fourth Quarter and Full Year 2025 Earnings Release Conference Call for March 19, 2026

    DENVER, March 05, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ:GRWG) ("GrowGen" or the "Company"), one of the nation's largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and retail garden centers, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, on Thursday, March 19, 2026, after market close. The announcement will be followed by a live earnings conference call at 4:30 p.m. ET. To participate in the call, please dial 1-(888)-699-1199 (domestic) or 1-(416)-945-7677 (international). The conference code is 21623. A recording of the webcast can be accesse

    3/5/26 8:00:00 AM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    Canopy Growth Announces MTL Cannabis Shareholder Approval of Acquisition

    Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) is pleased to announce that shareholders of MTL Cannabis Corp. ("MTL Cannabis" or "MTL") have voted to approve the Company's previously announced acquisition of MTL (the "Transaction") at a special meeting of shareholders of MTL (the "MTL Shareholders") held February 17, 2026. The plan of arrangement with Canopy Growth received overwhelming support from MTL Shareholders, with (i) 99.97% of all shares of MTL (the "MTL Shares") cast in favour of the special resolution approving the Transaction, and (ii) 99.80% of MTL Shares, excluding votes attached to MTL Shares required to be excluded pursuant to Multilat

    2/18/26 7:56:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    GrowGeneration Showcases New Strategic Co-Marketing and Sales Collaboration with Netafim at Indoor Ag-Con 2026

    DENVER, Feb. 04, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ:GRWG) ("GrowGen" or the "Company"), one of the nation's largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and retail garden centers, today announced that it will host an exhibit at the Indoor Ag-Con 2026 Conference, taking place February 11–12, 2026, in Las Vegas, Nevada. Details are included below: Indoor Ag-Con 2026Date: February 11–12, 2026Location: Westgate Las Vegas Resort & Casino – Las Vegas, NVBooth: 902Attendees: Jason Holland, VP of Product Innovation & Commercial Solutions; Steve Sevener, Viagrow Founder & VP of Lawn & Garden; Brandon Collins, Com

    2/4/26 8:00:00 AM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    $CARA
    $CGC
    $EAST
    $GENE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CGC
    $EAST
    $GENE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Mongeau Luc sold $9,951 worth of shares (9,376 units at $1.06), decreasing direct ownership by 1% to 802,992 units (SEC Form 4)

    4 - Canopy Growth Corp (0001737927) (Issuer)

    2/12/26 7:53:43 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Yanofsky Theresa sold $11,790 worth of shares (10,434 units at $1.13), decreasing direct ownership by 14% to 63,518 units (SEC Form 4)

    4 - Canopy Growth Corp (0001737927) (Issuer)

    1/2/26 4:38:18 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Lazzarato David Angelo sold $17,758 worth of shares (15,715 units at $1.13), decreasing direct ownership by 15% to 87,672 units (SEC Form 4)

    4 - Canopy Growth Corp (0001737927) (Issuer)

    1/2/26 4:37:09 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $CARA
    $CGC
    $EAST
    $GENE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Mongeau Luc bought $49,994 worth of shares (27,469 units at $1.82), increasing direct ownership by 3% to 812,368 units (SEC Form 4)

    4 - Canopy Growth Corp (0001737927) (Issuer)

    9/23/25 4:15:11 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Aiello Stephen bought $221,334 worth of shares (133,334 units at $1.66), increasing direct ownership by 25% to 668,311 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    9/23/25 4:00:54 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    President Salaman Michael bought $103,413 worth of shares (85,465 units at $1.21), increasing direct ownership by 6% to 1,639,313 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    3/20/25 3:54:41 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    $CARA
    $CGC
    $EAST
    $GENE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canopy Growth upgraded by The Benchmark Company

    The Benchmark Company upgraded Canopy Growth from Sell to Hold

    11/10/25 8:33:16 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Cara Therapeutics downgraded by Stifel with a new price target

    Stifel downgraded Cara Therapeutics from Buy to Hold and set a new price target of $1.00 from $6.00 previously

    6/13/24 7:05:24 AM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cara Therapeutics downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Cara Therapeutics from Buy to Hold and set a new price target of $1.00 from $10.00 previously

    6/13/24 7:05:04 AM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CGC
    $EAST
    $GENE
    Leadership Updates

    Live Leadership Updates

    View All

    Canopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada's Leading Medical Cannabis Business and Enhance Capacity to Serve Growing International Demand

    This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 All financial amounts in this press release are expressed in Canadian dollars. Highly accretive business combination expected to generate significant run-rate synergies of approximately $10 million within 18 months Strengthens Canopy Growth's presence in Québec with an opportunity to expand national distribution of MTL's high-quality, budtender-recommended product portfolio2 MTL's core management team is expected to join Canopy Growth to drive cultivation excellence and enhance the Company's p

    12/15/25 7:00:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Canopy Growth Announces Results of Annual General and Special Meeting of Shareholders

    Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, is pleased to announce today the voting results from its Annual General and Special Meeting of Shareholders convened on September 26, 2025 and adjourned to, and reconvened on, October 10, 2025 (the "Meeting"). All of the matters put forward before the Company's shareholders for consideration and approval, as set out in the Company's definitive proxy statement dated August 7, 2025 (the "Proxy Statement"), were approved by the requisite number of votes cast at the Meeting, as further detailed below. Each of t

    10/14/25 7:00:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Canopy Growth Appoints Tom Stewart as Chief Financial Officer

    Appointment finalizes CFO transition and reinforces Canopy Growth's focus on operational discipline, financial stability, and long-term value creation Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced that Tom Stewart has been appointed Chief Financial Officer, effective immediately. Mr. Stewart's appointment supports the continued execution of Canopy Growth's fiscal year 2026 strategy, which is marked by structural efficiency, operational and commercial focus, and disciplined capital allocation and cost management. With significant progres

    9/17/25 7:00:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $CARA
    $CGC
    $EAST
    $GENE
    Financials

    Live finance-specific insights

    View All

    GrowGeneration Announces Fourth Quarter and Full Year 2025 Earnings Release Conference Call for March 19, 2026

    DENVER, March 05, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ:GRWG) ("GrowGen" or the "Company"), one of the nation's largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and retail garden centers, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, on Thursday, March 19, 2026, after market close. The announcement will be followed by a live earnings conference call at 4:30 p.m. ET. To participate in the call, please dial 1-(888)-699-1199 (domestic) or 1-(416)-945-7677 (international). The conference code is 21623. A recording of the webcast can be accesse

    3/5/26 8:00:00 AM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    Canopy Growth to Report Third Quarter Fiscal 2026 Financial Results on February 6, 2026

    Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NASDAQ:CGC) will release its financial results for the third quarter fiscal year 2026 ended December 31, 2025 before financial markets open on February 6, 2026. Following the release of its third quarter fiscal year 2026 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Tom Stewart, CFO on February 6, 2026 at 10 AM Eastern Time (ET). Webcast Information A live audio webcast will be available at: https://onlinexperiences.com/Launch/QReg/ShowUUID=45C34153-5530-4D6A-A742-BC34AD2534FA Replay Information A replay will be accessible by webcast until 11:59 PM ET on May 7, 2026 at:

    1/23/26 7:00:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Canopy Growth Reports Second Quarter Fiscal 2026 Financial Results; Company Continues to Strengthen Financial Performance with Improving Adjusted EBITDA, Disciplined Cost Management, and a Stronger Balance Sheet

    Canada adult-use revenue up 30% in Q2 FY2026 and 37% year-to-date, reflecting the benefits of our focused commercial strategy and more disciplined execution Canada medical revenue up 17% in Q2 FY2026 and 15% year-to-date, marking another standout quarter for growth $298MM cash and cash equivalents, which exceeds debt balances by $70MM at September 30, 2025; as a result, conditions that previously raised substantial doubt concerning the Company's ability to continue as a going concern have been resolved Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced its financial results for the second quarter ended September 30, 2025 ("Q2 FY2026"). Al

    11/7/25 7:00:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $CARA
    $CGC
    $EAST
    $GENE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GrowGeneration Corp.

    SC 13G/A - GrowGeneration Corp. (0001604868) (Subject)

    11/12/24 3:53:28 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by GrowGeneration Corp.

    SC 13G/A - GrowGeneration Corp. (0001604868) (Subject)

    11/4/24 11:51:39 AM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    SEC Form SC 13D filed by Cara Therapeutics Inc.

    SC 13D - Cara Therapeutics, Inc. (0001346830) (Subject)

    10/30/24 4:21:50 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CGC
    $EAST
    $GENE
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary